The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $160.00

Today's change+2.00 +1.27%
Updated March 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $160.00

Today's change+2.00 +1.27%
Updated March 5 4:02 PM EST. Delayed by at least 15 minutes.

Perrigo Company PLC Hits New 20-day High

Perrigo Company PLC closed up Thursday by (U.S.)$2.00 or 1.27% to (U.S.)$160.00 and setting a new 20-day high. Over the last five days, shares have gained 3.06%, but are down 4.28% for the last year to date. Shares have underperformed the S&P 500 by 16.29% during the last year.

Key company metrics

  • Open(U.S.) $158.57
  • Previous close(U.S.) $158.00
  • High(U.S.) $160.32
  • Low(U.S.) $157.81
  • Bid / Ask(U.S.) $154.19 / (U.S.) $160.00
  • YTD % change-4.28%
  • Volume872,329
  • Average volume (10-day)1,124,309
  • Average volume (1-month)1,157,110
  • Average volume (3-month)971,188
  • 52-week range(U.S.) $125.37 to (U.S.) $172.00
  • Beta0.29
  • Trailing P/E62.24×
  • P/E 1 year forward21.54×
  • Forward PEG1.71×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield0.31%
  • Trailing EPS(U.S.) $2.57
Updated March 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.31%

Based on its net profit margin of 8.31%, Perrigo Company PLC is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 27, 201412/27/2014Sep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014
Revenue1,0729521,1441,004
Total other revenue--------
Total revenue1,0729521,1441,004
Gross profit384322416315
Total cost of revenue688630728689
Total operating expense897814947901
Selling / general / administrative144146170148
Research & development53373845
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1221120
Other operating expenses, total--------
Operating income175137198103
Interest income (expense), net non-operating-31-26----
Gain (loss) on sale of assets--------
Other--------
Income before tax8510916663
Income after tax709613248
Income tax, total15123415
Net income709613248
Total adjustments to net income--------
Net income before extra. items709613248
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items709613248
Inc. avail. to common incl. extra. items709613248
Diluted net income709613248
Dilution adjustment--------
Diluted weighted average shares137134134134
Diluted EPS excluding extraordinary itemsvalue per share0.510.720.980.36
Dividends per sharevalue per share0.110.110.110.11
Diluted normalized EPSvalue per share0.590.731.050.47